Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0042963
Disease: Vomiting
Vomiting
0.100 Biomarker phenotype HPO
CUI: C0042580
Disease: Vesico-Ureteral Reflux
Vesico-Ureteral Reflux
0.100 CausalMutation disease CLINVAR
CUI: C1833325
Disease: Thin bony cortex
Thin bony cortex
0.100 Biomarker phenotype HPO
CUI: C0231835
Disease: Tachypnea
Tachypnea
0.100 Biomarker phenotype HPO
CUI: C0423224
Disease: Sunken eyes
Sunken eyes
0.100 Biomarker phenotype HPO
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.100 Biomarker disease HPO
CUI: C4025790
Disease: Specific learning disability
Specific learning disability
0.100 Biomarker disease HPO
CUI: C0455792
Disease: Small scrotum
Small scrotum
0.100 Biomarker phenotype HPO
CUI: C1850573
Disease: Slender build
Slender build
0.100 Biomarker phenotype HPO
CUI: C2919142
Disease: Short Stature, CTCAE
Short Stature, CTCAE
0.100 Biomarker phenotype HPO
CUI: C0349588
Disease: Short stature
Short stature
0.100 Biomarker phenotype HPO
CUI: C0035579
Disease: Rickets
Rickets
0.100 Biomarker disease HPO
CUI: C0035229
Disease: Respiratory Insufficiency
Respiratory Insufficiency
0.100 Biomarker phenotype HPO
CUI: C0034050
Disease: Pulmonary Alveolar Proteinosis
Pulmonary Alveolar Proteinosis
0.010 GeneticVariation disease BEFREE <b>Rationale:</b> Pulmonary alveolar proteinosis (PAP) is characterized by filling of the alveolar spaces by lipoprotein-rich material of ill-defined composition, and is caused by molecularly different and often rare diseases that occur from birth to old age.<b>Objectives:</b> To perform a quantitative lipidomic analysis of lipids and the surfactant proteins A, B, and C in lavage fluids from patients with proteinosis of different causes in comparison with healthy control subjects.<b>Methods:</b> During the last two decades, we have collected BAL samples from patients with PAP due to autoantibodies against granulocyte-macrophage colony-stimulating factor; genetic mutations in CSF2RA (colony-stimulating factor 2 receptor α-subunit), MARS (methionyl aminoacyl-tRNA synthetase), FARSB (phenylalanine-tRNA synthetase, β-subunit), and NPC2 (Niemann-Pick disease type C2); and secondary to myeloid leukemia. 31002528 2019
CUI: C1837260
Disease: Prominent forehead
Prominent forehead
0.100 CausalMutation phenotype CLINVAR
CUI: C0020541
Disease: Portal Hypertension
Portal Hypertension
0.100 Biomarker disease HPO
CUI: C0206061
Disease: Pneumonia, Interstitial
Pneumonia, Interstitial
0.100 CausalMutation disease CLINVAR
Pathological accumulation of air in tissues
0.100 Biomarker phenotype HPO
CUI: C0030312
Disease: Pancytopenia
Pancytopenia
0.100 Biomarker disease HPO
CUI: C0029453
Disease: Osteopenia
Osteopenia
0.100 Biomarker disease HPO
CUI: C0079924
Disease: Oligohydramnios
Oligohydramnios
0.100 Biomarker phenotype HPO
CUI: C0026827
Disease: Muscle hypotonia
Muscle hypotonia
0.100 CausalMutation phenotype CLINVAR
CUI: C0026827
Disease: Muscle hypotonia
Muscle hypotonia
0.100 Biomarker phenotype HPO
CUI: C0025958
Disease: Microcephaly
Microcephaly
0.400 Biomarker disease GENOMICS_ENGLAND Homozygosity for FARSB mutation leads to Phe-tRNA synthetase-related disease of growth restriction, brain calcification, and interstitial lung disease. 30014610 2018
CUI: C0025958
Disease: Microcephaly
Microcephaly
0.400 Biomarker disease HPO